Latest Breaking News On - European commission for lamzede - Page 1 : comparemela.com

Chiesi Global Rare Diseases Announces FDA Approval of Lamzede®(velmanase alfa-tycv) for Alpha-Mannosidosis

Chiesi Global Rare Diseases Announces FDA Approval of Lamzede®(velmanase alfa-tycv) for Alpha-Mannosidosis
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomChiesi groupchiesiChiesi farmaceuticiGiacomo chiesiB corpGroup chiesiInternational society for mannosidosis related disordersDrug administrationMedia contactjenna urbanberry company public relationsChiesi groupEuropean commission for lamzedeGlobal rare diseasesChiesi global rareEuropean commissionMark stark

First FDA approval of enzyme replacement therapy for AM

The first and only enzyme replacement therapy approved for alpha-mannosidosis in the US has been cleared for adult and paediatric patients.

Giacomo chiesiEuropean medicines agencyChiesi groupDrug administrationCommittee for medicinal products human useEuropean commission for lamzedeChiesi global rare diseasesMedicinal productsHuman useEuropean commission